Hussman Strategic Advisors, Inc. Organogenesis Holdings Inc. Transaction History

Hussman Strategic Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 12, 2022	SELL	$4.74 - $8.15 $146,940 - $252,650	-31,000 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$14.92 - $23.23 $462,520 - $720,130	31,000 New	31,000 $515,000
Q4 2020 Feb 01, 2021	SELL	$3.63 - $7.53 $363,000 - $753,000	-100,000 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$3.29 - $4.58 $329,000 - $458,000	-100,000 Reduced 50.0%	100,000 $384,000
Q4 2019 Jan 31, 2020	BUY	$4.7 - $8.11 $940,000 - $1.62 Million	200,000 New	200,000 $962,000

119

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $466M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.